Shattuck Labs, Inc. (NASDAQ:STTK) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of shares of common stock and pre-funded warrants Update: about US$75M · US$4 a share · Leerink Partners +3 Dealers: Leerink Partners (co-lead), J.P. Morgan (co-lead), Piper Sandler (co-lead), Cantor (co-lead) | Jun 10, 2026 |
| Warrant exercise of common stock warrants Announced: about US$54.9M | Jun 9, 2026 |
| Private placement of common stock and common stock warrants Closed: US$103M raised · US$0.8677 a share · Warrants at US$1.0846 · Wedbush & Co., LLC Dealers: Wedbush & Co., LLC (lead) Buyers: OrbiMed (led the private placement); Coastlands Capital; Prosight Capital; Adage Capital; Redmile Group; NextBio Capital Use of proceeds: Fund operations into 2029 and advance SL-325 through clinical milestones, including randomized Phase 2 trials | Aug 26, 2025 |